Schizoaffective Disorders Completed Phase 4 Trials for Naltrexone (DB00704)

Also known as: Schizoaffective disorder / Schizophrenia schizoaffective / Schizoaffective psychosis / Schizo-affective type schizophrenia

IndicationStatusPhase
DBCOND0033299 (Schizoaffective Disorders)Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00453804Injectable Versus Oral Naltrexone Treatment of Alcohol Dependence In Serious Mental Illness (SMI)Treatment
NCT00453609Injectable Naltrexone Treatment of Alcohol Dependence in Serious Mental Illness (SMI)Treatment